Astrantus’s Manhattan Associates MANH Stock Holding History

Astrantus’s Portfolio MANH Stock Details MANH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,833	Closed	-$285K	–	247
2021 Q4	$285K	Buy	+1,833	New	+$298K	0.21%	173

Other funds holding MANH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Astrantus's MANH Position: Q1 2022 in Review

Astrantus sold out of Manhattan Associates (MANH) in Q1 2022, closing a stake of 1,833 shares — an estimated $285K sold.

Astrantus first reported a position in MANH in Q4 2021 and held it in 1 quarter. The position peaked at $285K in Q4 2021. 370 funds tracked by Wall St. Rank hold MANH as of Q1 2022.

Astrantus reported no remaining Manhattan Associates position as of Q1 2022 after selling out during the quarter.
Astrantus sold 1,833 Manhattan Associates shares in Q1 2022, an estimated $285K.
Astrantus first reported a position in Manhattan Associates in Q4 2021 and held it in 1 quarter.
Astrantus's Manhattan Associates position peaked at $285K in Q4 2021.
370 funds tracked by Wall St. Rank held Manhattan Associates as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.